Niche eczema solution Soteri Skin offers a unique non-steroidal, non-prescription, pH-balancing eczema treatment, suggesting collaboration opportunities with dermatology clinics, holistic skin care retailers, and direct-to-consumer channels targeting eczema patients.

Growth potential With under 1 million annual revenue and a recent funding round of 500K, there is likely appetite for partnerships, co-marketing, and channel expansion to accelerate revenue and increase market reach.

Digital commerce focus Existing tech stack includes Shopify and consumer-payment options (AfterPay, Google Pay), indicating readiness for direct-to-consumer sales initiatives, loyalty programs, and paid digital acquisition.

Limited headcount Small team (2-10 employees) implies scalable partnerships with white-label manufacturers, distributors, or contract sales resources to accelerate go-to-market without adding headcount.

Competitive positioning Positioning as a unique, non-steroidal eczema solution can be leveraged to form alliances with dermatology networks and skincare brands seeking complementary products, while targeting consumers exploring premium, non-prescription options.